Our commitment to medical needs, personalized solutions, and hi-tech technology is driven by our dedicated R&D and F&D centers. We focus on developing high-quality, cost-effective pharmaceutical and nutraceutical products that meet evolving global health demands and comply with international pharmacopeial standards (BP, USP, IP).
The R&D team constantly explores new molecules, conducts stability studies, and refines analytical methods. We invest extensively to ensure we are at the forefront of industry breakthroughs, providing our global clientele with innovative and quality-assured products across all therapeutic segments.
Method Development & Validation: Establishing and validating analytical procedures for new compositions.
Process Optimization: Scaling up laboratory batches to commercial production efficiently and reliably.
Novel Drug Delivery Systems: Working on advanced formulations like sustained-release (SR) and enteric-coated (EC) products (as seen in the CoPP list).
The F&D team is responsible for transforming raw active ingredients into stable, effective, and marketable final dosage forms. We specialize in developing generics, combinations, and customized nutraceutical formulations, covering your vast export list of Tablets, Capsules, Syrups, Suspensions, and specialized powders.
Dosage Form Diversity: Proven expertise in developing over 2000 products, including complex bilayered tablets and dry syrups.
Excipient Selection: Careful sourcing and qualification of excipients to ensure drug stability and bioavailability.
Clinical & Bioequivalence Support: Preparing documentation and providing technical support for registration in international markets.